Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
Biotin interference can lead to erroneous lab results in certain IVDs, including some troponin tests.
BioReference Health LLC and its parent company have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act.
The new guidelines will likely prove highly influential with oncologists and payors.
As the outbreak continues to grow in countries that have not historically seen monkeypox cases, testing companies are stepping up.
Recent FDA Safety Communication warns of the potential of false results from other sample types when testing for the monkeypox virus.
The agency needs a plan on use of EUA authority to get lab tests to market during the next public health emergency, says the GAO.
Here are the aspects of the proposed rule most likely to have an impact on labs and the businesses that own them.
Changes to PAMA reporting timelines and requirements, as well as payment cuts, are just some of the main takeaways labs should know about.
A total of 33 doctors have now paid settlements in relation to an alleged lab testing referrals scheme, according to the DOJ.
Research shows that AI algorithms trained with data collected from wearable devices were effective in identifying COVID-19.